世界のメタボロミクス（バイオマーカー発見/代謝物検知/代謝物プロファイル）市場...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT SCOPE
1.3 RESEARCH METHODOLOGY
1.4 KEY DATA POINTS FROM SECONDARY SOURCES

2 EXECUTIVE SUMMARY

3 METABOLOMICS –TECHNOLOGY LANDSCAPE ANALYSIS
3.1 INTRODUCTION
3.2 METABOLOMICS AND METABONOMICS
3.3 SEPARATION TECHNIQUES – HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
3.4 SEPARATION TECHNIQUES – CAPILLARY ELECTROPHORESIS (CE)
3.5 DETECTION TECHNIQUES – MASS SPECTROMETRY (MS)
3.6 DETECTION TECHNIQUES – NUCLEAR MAGNETIC RESONANCE (NMR)
3.7 DETECTION TECHNIQUES – SURFACE BASED MASS ANALYSIS
3.8 KEY APPLICATION AREAS
3.8.1 BIOMARKER DISCOVERY
3.8.2 DRUG DISCOVERY
3.8.3 TOXICITY ASSESSMENT/TOXICOLOGY
3.8.4 NUTRI-GENOMICS
3.9 CONCEPTUAL APPROACH
3.9.1 TARGET ANALYSIS
3.9.2 METABOLITE PROFILING
3.9.3 METABOLITE FINGERPRINTING
3.10 TECHNOLOGY TRENDS IN METABOLOMICS
3.11 VALUE CHAIN ANALYSIS

4 METABOLOMICS – MARKET LANDSCAPE ANALYSIS
4.1 GLOBAL METABOLOMICS MARKET SEGMENTATION
4.2 MARKET FORECAST
4.2.1 GLOBAL METABOLOMICS MARKET REVENUE FORECAST – INTRODUCTION
4.2.2 GLOBAL METABOLOMICS MARKET REVENUE – REGIONAL
4.2.3 GLOBAL METABOLOMICS MARKET REVENUE – INDICATION
4.2.4 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 CHALLENGES
4.3.4 EMERGING TRENDS
4.4 DEMAND SIDE ANALYSIS

5 METABOLOMICS – TECHNOLOGY INVESTMENT POTENTIAL 70-81
5.1 INVESTMENT CLIMATE ASSESSMENT
5.1.1 INVESTMENT CLIENT NETWORKS
5.1.1.1 FUNDING BODIES
5.1.1.2 INSIGHTS ON CURRENT & FUTURE TECH-INVESTMENT TREND
5.1.2 FUNDING OPPORTUNITIES
5.1.3 ANALYSIS OF POTENTIAL AREAS FOR TECHNOLOGY INVESTMENT USING STRATEGIC EVALUATION

6 METABOLOMICS – GEOGRAPHICAL ANALYSIS
6.1 INTRODUCTION
6.2 U.S., CANADA, MEXICO
6.3 EUROPE
6.4 ASIA & REST OF THE WORLD (ROW)

7 COMPETITIVE LANDSCAPE ANALYSIS
7.1 MERGERS & ACQUISITIONS
7.2 NEW PRODUCT DEVELOPMENTS
7.3 COLLABORATIONS

8 PATENT ANALYSIS
8.1 PATENT ANALYSIS

9 TECHNOLOGY ANALYSIS (USING MULTI CRITERIA DECISION MAKING) & ROAD MAPPING 94-100
9.1 LEVEL 0 CRITERIA DESCRIPTION
9.2 COMPARISON OF DEVICES BASED ON LEVEL 0 CRITERIA
9.3 TECHNOLOGY PRIORITIZATION AND AHP ANALYSIS FINDINGS
9.4 TECHNOLOGY ROADMAP

10 ANALYST INSIGHTS & RECOMMENDATIONS
10.1 ANALYST INSIGHTS
10.2 STRATEGIC RECOMMENDATIONS FOR TECHNOLOGY & BUSINESS MANAGEMENT

11 COMPANY PROFILES
11.1 AGILENT TECHNOLOGIES
11.2 BRUKER CORPORATION
11.3 METABOLOMIC TECHNOLOGIES
11.4 METABOLON
11.5 CHENOMX
11.6 BIO-RAD LABORATORIES
11.7 WATERS CORPORATION
11.8 HUMAN METABOLOME TECHNOLOGIES
11.9 NEXTGEN METABOLOMICS
11.10 BIOCRATES LIFE SCIENCES AG
11.11 STEMINA BIOMARKER
11.12 PHENOMENOME
11.13 METANOMICS GMBH
11.14 ACCELRYS
11.15 EISAI CO. LTD.
11.16 SHIMADZU CORPORATION
11.17 SIDMAP, LLC
11.18 ASTRAZENECA PLC
11.19 AB SCIEX
11.2 METABOLOMX
11.21 RESEARCH INSTITUTE OF CHROMATOGRAPHY (RIC)

12 APPENDIX
12.1 KEY PATENTS

13 GLOSSARY